Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Randall E Harris

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
International Journal of Cancer|April 1, 2004
Non-Hodgkin's lymphoma and nonsteroidal anti-inflammatory drugs: a confounding problem?Randall E Harris
Science (New York, N.Y.)|April 12, 2005
Does the dose make the poison?Randall E Harris
Idrugs : the Investigational Drugs Journal|December 2, 2006
Antiangiogenesis: New Frontiers in Therapeutic Development--IBC's Fourth Annual International SymposiumRandall E Harris
Sub-Cellular Biochemistry|July 7, 2007
Cyclooxygenase-2 (cox-2) and the inflammogenesis of cancerRandall E Harris
Inflammopharmacology|May 9, 2018
Cyclooxygenase and lipoxygenase gene expression in the inflammogenesis of breast cancerBrian M Kennedy, Randall E Harris
Cancers|May 16, 2023
Cyclooxygenase and Lipoxygenase Gene Expression in the Inflammogenesis of Colorectal Cancer: Correlated Expression of EGFR, JAK STAT and Src Genes, and a Natural Antisense Transcript, RP11-C67.2.2Brian M Kennedy, Randall E Harris
Frontiers in Oncology|October 21, 2022
Celecoxib may be a viable treatment option for breast cancer patients not treated with chemotherapyRandall E Harris, Judith A Schwartzbaum
Journal of Experimental Pharmacology|May 18, 2016
Reduction in cancer risk by selective and nonselective cyclooxygenase-2 (COX-2) inhibitorsRandall E Harris, Joanne Beebe, Galal A Alshafie
BMC Cancer|February 1, 2006
Reduction in the risk of human breast cancer by selective cyclooxygenase-2 (COX-2) inhibitorsRandall E Harris, Joanne Beebe-Donk, Galal A Alshafie
Molecular and Clinical Oncology|June 8, 2017
Ibuprofen and fatal lung cancer: A brief report of the prospective results from the Third National Health and Nutrition Examination Survey (NHANES III)Marisa A Bittoni, David P Carbone, Randall E Harris
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
International Journal of Cancer|April 1, 2004
Non-Hodgkin's lymphoma and nonsteroidal anti-inflammatory drugs: a confounding problem?Randall E Harris
Science (New York, N.Y.)|April 12, 2005
Does the dose make the poison?Randall E Harris
Idrugs : the Investigational Drugs Journal|December 2, 2006
Antiangiogenesis: New Frontiers in Therapeutic Development--IBC's Fourth Annual International SymposiumRandall E Harris
Sub-Cellular Biochemistry|July 7, 2007
Cyclooxygenase-2 (cox-2) and the inflammogenesis of cancerRandall E Harris
Inflammopharmacology|May 9, 2018
Cyclooxygenase and lipoxygenase gene expression in the inflammogenesis of breast cancerBrian M Kennedy, Randall E Harris
Cancers|May 16, 2023
Cyclooxygenase and Lipoxygenase Gene Expression in the Inflammogenesis of Colorectal Cancer: Correlated Expression of EGFR, JAK STAT and Src Genes, and a Natural Antisense Transcript, RP11-C67.2.2Brian M Kennedy, Randall E Harris
Frontiers in Oncology|October 21, 2022
Celecoxib may be a viable treatment option for breast cancer patients not treated with chemotherapyRandall E Harris, Judith A Schwartzbaum
Journal of Experimental Pharmacology|May 18, 2016
Reduction in cancer risk by selective and nonselective cyclooxygenase-2 (COX-2) inhibitorsRandall E Harris, Joanne Beebe, Galal A Alshafie
BMC Cancer|February 1, 2006
Reduction in the risk of human breast cancer by selective cyclooxygenase-2 (COX-2) inhibitorsRandall E Harris, Joanne Beebe-Donk, Galal A Alshafie
Molecular and Clinical Oncology|June 8, 2017
Ibuprofen and fatal lung cancer: A brief report of the prospective results from the Third National Health and Nutrition Examination Survey (NHANES III)Marisa A Bittoni, David P Carbone, Randall E Harris
Pageof 4